GenBio AI is pioneering the development of the world's first AI-Driven Digital Organism (AIDO) aimed at transforming medical and life sciences. The company integrates multiscale foundation models to simulate, program, and predict complex biological outcomes. Their revolutionary approach empowers researchers in medicine, drug discovery, and longevity research, enabling unprecedented insights into biological systems. Led by a team of experts in AI, machine learning, and biology, GenBio AI aims to leverage transformative technology for scientific exploration.